Hemant Surgical Industries Ltd (HSIL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Hemant Surgical Industries Ltd on NSE and BSE, with an AI summary of each filing.
Scrutinizer Report and Voting result of AGM held on September 29, 2026
Annual General Meeting · 30 Sept 2026, 12:53 am
Proceeding of AGM held on Tuesday, September 29, 2026
Annual General Meeting · 30 Sept 2026, 12:19 am
The Company has sent letters to those shareholders whose email addresses are not registered.
Others (Uncategorized) · 05 Sept 2026, 1:37 am
Hemant Surgical Industries Discloses 37th AGM Schedule and Dispatch Details Hemant Surgical Industries has notified shareholders regarding its 37th Annual General Meeting scheduled for 29th Sep'26 at 12:30 PM IST via video conferencing. The company issued communications providing access links to the AGM Notice and FY25-26 Integrated Annual Report for shareholders whose email addresses are unregistered. The cut-off date to determine voting eligibility is set for 22nd Sep'26. Remote e-voting opens on 26th Sep'26 at 9:00 AM IST and concludes on 28th Sep'26 at 5:00 PM IST.
Notice of AGM and Integrated Annual Report for F.Y. 25-26
Others (Uncategorized) · 05 Sept 2026, 1:33 am
37th AGM of the Company is scheduled to be held on September 29, 2026 through VC/OAVM.
Annual General Meeting · 05 Sept 2026, 1:29 am
The Company has considered and decided to hold AGM of the Company on September 29, 2026 through VC/OAVM.
Others (Uncategorized) · 29 Aug 2026, 5:59 pm
In continuation to disclosure dated March 31, 2026, minor modification have been made in attached disclosure.
Others (Uncategorized) · 09 Jun 2026, 11:30 pm
HSIL Revises SKD Manufacturing Agreement with Sonomed Escalon, USA Hemant Surgical Industries Ltd., on Jun 09, '26, filed a revised disclosure for its agreement with Sonomed Escalon, USA. The purpose is to undertake Semi Knocked Down (SKD) manufacturing in India for two models of ophthalmic ultrasound devices (A-scan and pachymetry). These devices are for exclusive distribution within the Indian market. Sonomed Escalon will supply the kits at a preferential "Transfer Price," with the transaction not classified as a related-party deal. The revision was requested by Sonomed for investor clarity.
Please find enclosed Press Release being issued by the Company titled "Hemant Surgical Strengthens Healthcare Portfolio through Strategic Acquisition of Majority Stake in Lifesenz Cancer ....
Press Release · 09 Jun 2026, 6:57 pm
Hemant Surgical Acquires 66.66% Stake in Oncology Firm Lifesenz Hemant Surgical Industries has acquired a 66.66% majority stake in Lifesenz Cancer Research Labs for Rs. 19.98 Crores, effective 01 Jun'26. This strategic acquisition expands Hemant Surgical's portfolio into the high-growth precision oncology segment. Lifesenz specializes in personalized cancer treatments using advanced ex-vivo chemo-sensitivity analysis. While Lifesenz is in a growth phase and not yet profitable, the acquisition is viewed as a long-term strategic investment to enhance Hemant's healthcare offerings, leverage its distribution network, and drive future value in advanced diagnostics.
With reference to intimation dated May 27, 2026, the Company has completed the acqusition of Lifesenz Cancer Labs Private Limited and has become subsidiary of the Company w.e.f. June 01, 2026.
Others (Uncategorized) · 01 Jun 2026, 8:02 pm
Hemant Surgical Completes Acquisition of Lifesenz Cancer Research Labs Hemant Surgical Industries Ltd. has completed the acquisition of Mumbai-based Lifesenz Cancer Research Labs Private Limited. Following the completion on Jun 01, '26, Lifesenz has officially become a subsidiary of Hemant Surgical. This follows the company's initial intimation on the matter dated May 27, '26.
The Company at its meeting held today i.e., May 27, 2026 has entered into Share Purchase Agreement (''SPA'') for acquisition of 66.66% equity shareholding of Lifesenz Cancer Labs Private ....
Others (Uncategorized) · 27 May 2026, 11:40 pm
Hemant Surgical to Acquire 66.66% of Lifesenz Cancer Research Labs Hemant Surgical Industries will acquire a 66.66% equity stake in Lifesenz Cancer Research Labs for Rs. 19.99 crore in cash. The deal, a related-party transaction, aims to strengthen its presence in healthcare and cancer diagnostics. For FY25, Lifesenz reported a turnover of Rs. 56.75 lakhs, a PAT of Rs. (74.76) lakhs, and a negative net worth of Rs. (221.84) lakhs. Post-acquisition, Lifesenz will become a subsidiary. The transaction is expected to be completed by 30th Sep'26.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Singularity Equity Fund I
Acquisition/ Disposal of Shares · 20 May 2026, 3:39 pm
Singularity Equity Fund I Boosts Stake in Hemant Surgical Industries Singularity Equity Fund I acquired 6,49,600 equity shares of Hemant Surgical Industries Ltd on 15 May'26 via the conversion of warrants from a preferential allotment. This transaction increased the fund's holding from 2,49,600 shares (1.91% stake) to 8,99,200 shares. Post-acquisition, Singularity Equity Fund I's stake now stands at 6.90% of the total share capital and 6.19% on a fully diluted basis. The acquisition raises the target company's total equity share capital from Rs. 13.04 Cr to Rs. 14.54 Cr.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Singularity Large Value Fund III
Acquisition/ Disposal of Shares · 20 May 2026, 3:37 pm
Singularity Large Value Fund III Raises Stake in Hemant Surgical Industries Singularity Large Value Fund III acquired 6,49,600 equity shares in Hemant Surgical Industries Ltd on May 15, '26, through the conversion of warrants. This transaction increased its holding from 2,49,600 shares (1.91% of total capital) to 8,99,200 shares. Consequently, the fund's stake rose to 6.90% of the total share capital and 6.19% on a fully diluted basis. The acquisition was executed via a preferential allotment, increasing the company's total voting capital to Rs. 14,53,76,000.
Allotment of 14,99,200 Equity Shares consequent to conversion of Convertible Warrants
Others (Uncategorized) · 15 May 2026, 11:36 pm
Hemant Surgical Allots 14.99 Lakh Shares on Warrant Conversion On 15 May'26, Hemant Surgical Industries allotted 14,99,200 equity shares of ₹10 face value at an issue price of ₹197 per share. This allotment follows the conversion of warrants on a preferential basis to non-promoter shareholders, including Singularity Large Value Fund and Singularity Equity Fund. Consequently, the company's paid-up equity share capital has increased from ₹13.04 cr to ₹14.54 cr. The allotment was made upon receipt of the balance 75% of the subscription money for the warrants.
The Board of Directors at its meeting held today has appointment M/s. K Sorathiya & Co, Practicing Cost Accountants as Cost Auditor of the Company for F.Y. 26-27
Change in Auditor · 15 May 2026, 11:06 pm
Hemant Surgical Industries Appoints Cost Auditor for FY27 Hemant Surgical Industries Ltd.'s Board of Directors has appointed M/s K Sorathiya & Co, Practicing Cost Accountants, as the company's Cost Auditor for the financial year 2026-27. The appointment was approved at the board meeting on 15 May'26, based on the recommendation of the Audit Committee. K Sorathiya & Co has been practicing since Feb'19 and possesses experience in accounts, costing, taxation, and finance.
The Board of Directors at its Meeting held today has appointed M/s. A D M S and Company, Chartered Accountant as Internal Auditor of the Company for F.Y. 26-27
Change in Auditor · 15 May 2026, 10:58 pm
Hemant Surgical Appoints New Internal Auditor for FY27 Hemant Surgical Industries Ltd. has appointed M/s. A D M S and Company, Chartered Accountant, as its Internal Auditor for the financial year 2026-27. The appointment was approved by the Board of Directors on May 15, '26, following a recommendation from the Audit Committee. A D M S and Company is a Mumbai-based firm with experience in statutory, internal, stock, and tax audits. The company confirmed no disclosed relationships exist between the new auditor and the company's directors.
The Board of Directors at its Meeting held today has appointed M/s. NKM & Associates as Secretarial Auditor of the Company for F.Y. 26-27
Change in Auditor · 15 May 2026, 10:55 pm
Hemant Surgical Appoints NKM & Associates as Secretarial Auditor for FY27 Hemant Surgical Industries Ltd.'s Board of Directors, based on the Audit Committee's recommendation, has appointed M/s. NKM and Associates as the Secretarial Auditor for the financial year 2026-27. The appointment was approved during the board meeting held on 15 May'26. NKM & Associates, founded in 2018 by Ms. Nikita Kedia, specializes in corporate law, secretarial audits, and listing compliances.
Audited Financial Results of the Company for half and financial year ended March 31, 2026
Financial Result · 15 May 2026, 10:43 pm
Hemant Surgical Industries Ltd. - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 16719 (+189.4% YoY | +158.7% QoQ) ■ EBITDA: 1557 (+185.7% YoY | +103.4% QoQ) ■ EBITDA Margin (%): 9.3 (-12 bps YoY | -253 bps QoQ) ■ PAT: 1273 (+162.0% YoY | +133.2% QoQ) ■ EPS (INR): 9.84 (+111.6% YoY | +92.9% QoQ)
The Board of Directors at its meeting held today have approved Audited Financial Results of the Company for half and financial year ended March 31, 2026
Outcome · 15 May 2026, 10:21 pm
Hemant Surgical Industries Ltd. - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakhs) ■ Revenue: 16719 (+189.4% YoY | +158.7% QoQ) ■ EBITDA: 1557 (+185.7% YoY | +103.4% QoQ) ■ EBITDA Margin (%): 9.3 (-12 bps YoY | -253 bps QoQ) ■ PAT: 1273 (+162.0% YoY | +133.2% QoQ) ■ EPS (INR): 9.84 (+111.6% YoY | +92.9% QoQ)
Hemant Surgical Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve Audited Standalone ....
Intimation · 15 May 2026, 5:30 am
Hemant Surgical Board Meeting on 15th May'26 for FY26 Results Hemant Surgical Industries Ltd. will hold a Board Meeting on 15th May'26 to consider and approve the audited standalone and consolidated financial results for the half-year and financial year ended 31st Mar'26. The trading window for designated persons has been closed since 01st Apr'26 and will reopen 48 hours after the results are declared. This meeting is pursuant to Regulation 29 of the SEBI (LODR) Regulations, 2015.
The Company has executed C-ARM Development and Supply Agreement with GBT Korea Co, Ltd, Republic of Korea.
Others (Uncategorized) · 02 Apr 2026, 6:11 pm
Hemant Surgical Enters C-ARM Development and Supply Agreement with GBT Korea Hemant Surgical Industries Ltd. entered a C-ARM Development and Supply Agreement with GBT Korea Co., Ltd. on Apr 02, '26. The collaboration aims to leverage GBT Korea's technological expertise to develop and localize x-ray generators and c-arm imaging devices. These devices will provide real-time, high-resolution imaging for surgical orthopaedic, trauma, and cardiovascular procedures. The size of the agreement remains undisclosed due to confidentiality clauses. The transaction is not with a related party.
The Company has entered into Strategic Semi Knocked Down (SKD) Manufacturing Agreement with Sonomed Escalon, USA
Others (Uncategorized) · 01 Apr 2026, 4:29 am
Hemant Surgical Enters Manufacturing Agreement with Sonomed Escalon, USA Hemant Surgical Industries Ltd. announced on 31 Mar'26 it has entered into a strategic Semi Knocked Down (SKD) manufacturing agreement with Sonomed Escalon, USA. The partnership aims to localize manufacturing for ophthalmic ultrasound diagnostic devices in India, with Sonomed Escalon supplying SKD kits at a preferential transfer price. The agreement is not a related-party transaction, though Hemant Surgical's promoter was previously an authorized distributor for Sonomed. This move supports the company's goal of achieving 100% local manufacturing for these devices.
Intimation of receipt of purchase order from Central Medical Services Society, Ministry of Health and Family Welfare (Government of India).
Others (Uncategorized) · 19 Feb 2026, 7:33 pm
Hemant Surgical Wins Rs. 264.33 Crore Government Purchase Order Hemant Surgical Industries Ltd. secured purchase orders worth Rs. 264.33 crores from India's Central Medical Service Society (CMSS). The orders, dated Dec'25, are for the supply of Flat Panel Detectors and related utilities. While final commercial terms like the delivery schedule are still under discussion, the company has agreed to commence interim supplies due to the project's national importance. The entire order is expected to be executed in tranches by 30th Sep'26, subject to final negotiations and terms.
Statement of Deviation or Variation for half year ended on September 30, 2025
Others (Uncategorized) · 12 Nov 2025, 11:35 pm
Statement of Deviation or Variation for the half year ended on September 30, 2025.
Others (Uncategorized) · 12 Nov 2025, 11:31 pm
Unaudited financial results of the Company for the half year ended on September 30, 2025.
Financial Result · 12 Nov 2025, 11:13 pm